<unk>  is thought to affect more than 14 million people worldwide, with allergic bronchopulmonary<unk>  (ABPA, >4 million), severe asthma with fungal sensitization (>6.5 million), and chronic pulmonary<unk>  (CPA, ~3 million) being considerably more prevalent than invasive<unk>  (IA, >300,000). Other common conditions include Aspergillus bronchitis, Aspergillus rhinosinusitis (many millions), otitis externa, and Aspergillus onychomycosis (10 million). Alterations in the composition and function of the lung microbiome and mycobiome have been associated with an increasing number of chronic pulmonary diseases such as COPD, cystic fibrosis, chronic rhinosinusitis and asthma.
Aspergillosis
Phaeohyphomycosis
Aspergilloma
Mucormycosis
Histoplasmosis
Tuberculosis
Lobomycosis
Sycosis